Basic considerations on magnesium in the management of neurocritical patients

다국어 초록 (Multilingual Abstract)

Magnesium is an essential chemical element in human life. In the brain, it is physiologically responsible for a large number of processes involved in intracellular homeostasis, blood-brain barrier integrity, protein synthesis, neuronal proliferation, aging, and apoptosis. Considering that neurocritical care is a relatively new discipline in certain regions of the world and is an independent protective factor of neurological diseases in critical care, it is essential to disseminate basic concepts and utilities of tools that can positively impact the neurological disease burden. Magnesium and its use in neurocritical care are poorly understood. Therefore, this study aimed to review basic concepts regarding the physiology of magnesium in neurological dynamics, its role in the pathophysiology of neurological disorders, and the outcome of its use in the management of neurocritical illnesses.

참고문헌 (Reference)

1 Matsui Y, "Visualization of long-term Mg2+ dynamics in apoptotic cells using a novel targetable fluorescent probe" 8 : 8255-8264, 2017

2 Abbott NJ, "Transporting therapeutics across the blood-brain barrier" 2 : 106-113, 1996

3 Allsop TF, "Transfer of magnesium across the perfused choroid plexus of sheep" 39 : 161-169, 1986

4 Panahi Y, "The role of magnesium sulfate in the intensive care unit" 16 : 464-482, 2017

5 Kirkland AE, "The role of magnesium in neurological disorders" 10 : 730-, 2018

6 Botturi A, "The role and the effect of magnesium in mental disorders : a systematic review" 12 : 1661-, 2020

7 Amiry-Moghaddam M, "The molecular basis of water transport in the brain" 4 : 991-1001, 2003

8 Varelas PN, "The impact of a neurointensivist-led team on a semiclosed neurosciences intensive care unit" 32 : 2191-2198, 2004

9 Porcayo-Liborio S, "The evolution of neuro-critical care in Mexico" 33 : 50-55, 2010

10 Xue W, "The effect of magnesium deficiency on neurological disorders : a narrative review article" 48 : 379-387, 2019

11 Bechler K, "The effect of early treatment with intravenous magnesium sulfate on the incidence of cardiac comorbidities in hospitalized stroke patients" 2020 : 1494506-, 2020

12 Abbott NJ, "Structure and function of the blood-brain barrier" 37 : 13-25, 2010

13 Stangherlin A, "Signal transduction : magnesium manifests as a second messenger" 28 : R1403-R1405, 2018

14 Jafari M, "Serum magnesium level and hematoma expansion in patients with intracerebral hemorrhage" 398 : 39-44, 2019

15 Larsson SC, "Serum magnesium and calcium levels in relation to ischemic stroke : Mendelian randomization study" 92 : e944-e950, 2019

16 Stippler M, "Serum and cerebrospinal fluid magnesium in severe traumatic brain injury outcome" 24 : 1347-1354, 2007

17 Sun Q, "Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration" 108 : 426-439, 2016

18 Seyama T, "Pretreatment with magnesium sulfate attenuates white matter damage by preventing cell death of developing oligodendrocytes" 44 : 601-607, 2018

19 Saver JL, "Prehospital use of magnesium sulfate as neuroprotection in acute stroke" 372 : 528-536, 2015

20 Saver JL, "Prehospital neuroprotective therapy for acute stroke : results of the Field Administration of Stroke Therapy-Magnesium(FAST-MAG)pilot trial" 35 : e106-e108, 2004

21 van den Bergh WM, "Potentials of magnesium treatment in subarachnoid haemorrhage" 17 : 301-313, 2004

22 Bara M, "Potassium, magnesium and membranes : review of present status and new findings" 3 : 215-225, 1984

23 Shkirkova K, "Paramedic initiation of neuroprotective agent infusions : successful achievement of target blood levels and attained level effect on clinical outcomes in the FAST-MAG pivotal trial(field administration of stroke therapy-magnesium)" 48 : 1901-1907, 2017

24 Xu R, "Neuroprotective effect of magnesium supplementation on cerebral ischemic diseases" 272 : 119257-, 2021

25 Michael G. Ortega-Sierra, "Neuroeducation and neurorehabilitation in the neurosurgical patient: programs to be developed in Latin America and the Caribbean" Edizioni Minerva Medica 2021

26 Kramer AH, "Neurocritical care : a growing international collaborative" 32 : 80-83, 2020

27 Liotta EM, "Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage" 89 : 813-819, 2017

28 Wong GK, "Magnesium sulphate for aneurysmal subarachnoid hemorrhage : why, how, and current controversy" 115 : 45-48, 2013

29 van den Bergh WM, "Magnesium sulfate in aneurysmal subarachnoid hemorrhage : a randomized controlled trial" 36 : 1011-1015, 2005

30 Zeiler FA, "Magnesium sulfate for non-eclamptic status epilepticus" 32 : 100-108, 2015

31 Li W, "Magnesium sulfate for acute traumatic brain injury" 26 : 393-398, 2015

32 McKee JA, "Magnesium neuroprotection is limited in humans with acute brain injury" 2 : 342-351, 2005

33 Yamanaka R, "Magnesium is a key player in neuronal maturation and neuropathology" 20 : 3439-, 2019

34 Vink R, "Magnesium in the central nervous system" University of Adelaide Press 2011

35 Gröber U, "Magnesium in prevention and therapy" 7 : 8199-8226, 2015

36 Volpe SL, "Magnesium in disease prevention and overall health" 4 : 378S-383S, 2013

37 Maas AI, "Magnesium for neuroprotection after traumatic brain injury" 6 : 20-21, 2007

38 Dorhout Mees SM, "Magnesium for aneurysmal subarachnoid haemorrhage(MASH-2) : a randomised placebo-controlled trial" 380 : 44-49, 2012

39 Allsop TF, "Magnesium concentrations in the ventricular and lumbar cerebrospinal fluid of hypomagnesaemic cows" 38 : 61-64, 1985

40 Jahnen-Dechent W, "Magnesium basics" 5 (5): i3-i14, 2012

41 Venkatasubba Rao CP, "Magnesium and neuroprotection in subarachnoid haemorrhage" 380 : 9-11, 2012

42 McLean RM, "Magnesium and its therapeutic uses : a review" 96 : 63-76, 1994

43 Amory CF, "Magnesium and hydrogen in subarachnoid hemorrhage : is neuroprotection finally a reality" 52 : 28-30, 2021

44 Chang JJ, "Magnesium : pathophysiological mechanisms and potential therapeutic roles in intracerebral hemorrhage" 14 : 1116-1121, 2019

45 Suarez JI, "Length of stay and mortality in neurocritically ill patients : impact of a specialized neurocritical care team" 32 : 2311-2317, 2004

46 Wong GK, "Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage(IMASH) : a randomized, double-blinded, placebo-controlled, multicenter phase III trial" 41 : 921-926, 2010

47 Takeuchi S, "Intravenous hydrogen therapy with intracisternal magnesium sulfate infusion in severe aneurysmal subarachnoid hemorrhage" 52 : 20-27, 2021

48 Sitzia C, "Intra-erythrocytes magnesium deficiency could reflect cognitive impairment status due to vascular disease : a pilot study" 18 : 458-, 2020

49 Godoy DA, "Intensive care in severe cranioencephalic trauma" 23 : 193-220, 2016

50 Pan WH, "Intake of potassium-and magnesium-enriched salt improves functional outcome after stroke : a randomized, multicenter, double-blind controlled trial" 106 : 1267-1273, 2017

51 Topf JM, "Hypomagnesemia and hypermagnesemia" 4 : 195-206, 2003

52 Van Laecke S, "Hypomagnesemia and hypermagnesemia" 74 : 41-47, 2019

53 Pham PC, "Hypomagnesemia : a clinical perspective" 7 : 219-230, 2014

54 Gragossian A, "Hypomagnesemia" StatPearls Publishing 2021

55 Cascella M, "Hypermagnesemia" StatPearls Publishing 2021

56 World Health Organization, "Global burden of neurological disorders:estimates and projections" World Health Organization

57 Spasov AA, "Features of central neurotransmission in animals in conditions of dietary magnesium deficiency and after its correction" 39 : 645-653, 2009

58 Bokhari SR, "Fatal hypermagnesemia due to laxative use" 355 : 390-395, 2018

59 Schelling JR, "Fatal hypermagnesemia" 53 : 61-65, 2000

60 Macías-Ruíz VS, "Factors associated with mortality of spontaneous intraparenchymal cerebral hemorrhage in patients over 50 years of age who attended the teodoro maldonado carbo hospital during the year 2017" 28 : 10-15, 2019

61 Lai TW, "Excitotoxicity and stroke : identifying novel targets for neuroprotection" 115 : 157-188, 2014

62 Abbott NJ, "Evidence for bulk flow of brain interstitial fluid : significance for physiology and pathology" 45 : 545-552, 2004

63 Butt AM, "Electrical resistance across the blood-brain barrier in anaesthetized rats : a developmental study" 429 : 47-62, 1990

64 Soliman R, "Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage : a randomized study" 69 : 64-71, 2019

65 Lyons MW, "Does magnesium sulfate have a role in the management of severe traumatic brain injury in civilian and military populations? A systematic review and meta-analysis" 164 : 442-449, 2018

66 Altman D, "Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial : a randomised placebo-controlled trial" 359 : 1877-1890, 2002

67 Fang X, "Dietary magnesium intake and the risk of cardiovascular disease, type 2diabetes, and all-cause mortality : a dose-response meta-analysis of prospective cohort studies" 14 : 210-, 2016

68 Gomes D, "Consensus protocol for the treatment of super-refractory status epilepticus" 31 : 598-605, 2018

69 Martin KJ, "Clinical consequences and management of hypomagnesemia" 20 : 2291-2295, 2009

70 Mejía C JA, "Cerebral vasospasm secondary to subarachnoid hemorrhage due to ruptured intracerebral aneurysm" 35 : 143-162, 2007

71 Findlay JM, "Cerebral vasospasm : a review" 43 : 15-32, 2016

72 Wolahan SM, "Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects" CRC Press/Taylor & Francis 2015

73 Agre P, "Aquaporin CHIP : the archetypal molecular water channel" 265 (265): F463-F476, 1993

74 Barbosa FT, "Applications of magnesium sulfate in obstetrics and anesthesia" 60 : 104-110, 2010

75 Broman M, "Analysis of hypo-and hypermagnesemia in an intensive care unit cohort" 62 : 648-657, 2018

76 Lee JS, "A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats" 21 : 549-561, 2004

77 Belfort MA, "A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia" 348 : 304-311, 2003